Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Gynecologic Oncology|December 22, 2005
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group StudyJoan L Walker, Deborah K Armstrong, Helen Q Huang, et al.
Gynecologic Oncology|July 10, 2007
Pathologic findings and outcomes for octogenarians presenting with uterine malignancyKathleen N Moore, Grainger S Lanneau, Chad Smith, et al.
Gynecologic Oncology|November 9, 2007
Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion ratesLisa M Landrum, Michael A Gold, Kathleen N Moore, et al.
Gynecologic Oncology|April 13, 2013
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group studyLisa M Landrum, James Java, Cara A Mathews, et al.
Gynecologic Oncology|June 2, 2007
Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern eraLisa M Landrum, Grainger S Lanneau, Valerie J Skaggs, et al.
Frontiers in Oncology|April 26, 2018
Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto RicoCharles A Kunos, Holly A Massett, Annette Galassi, et al.
American Journal of Clinical Oncology|April 26, 2003
Impact of individual physicians on enrollment of patients into clinical trialsRobert S Mannel, Joan L Walker, Natalie Gould, et al.
Gynecologic Oncology|December 15, 2010
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology GroupBradley J Monk, Michael W Sill, Parviz Hanjani, et al.
Oecologia|November 21, 2014
Historical agriculture alters the effects of fire on understory plant beta diversityW Brett Mattingly, John L Orrock, Cathy D Collins, et al.
Gynecologic Oncology|November 15, 2011
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group studyDavid H Moore, Shamshad Ali, Wui-Jin Koh, et al.
Pageof 15